These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 28333866
1. Prevention of gastrointestinal side-effects in paediatric oncology: what are the guidelines? Cheng KKF. Curr Opin Support Palliat Care; 2017 Jun; 11(2):120-124. PubMed ID: 28333866 [Abstract] [Full Text] [Related]
2. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis. Natale JJ. Hosp Pract (1995); 2015 Jun; 43(4):226-34. PubMed ID: 26308912 [Abstract] [Full Text] [Related]
3. Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents. Navari RM. J Support Oncol; 2003 Jun; 1(2):89-103. PubMed ID: 15352652 [Abstract] [Full Text] [Related]
4. Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-day granisetron for CINV in a randomized, single-blinded crossover study. Kimura H, Yamamoto N, Shirai T, Nishida H, Hayashi K, Tanzawa Y, Takeuchi A, Igarashi K, Inatani H, Shimozaki S, Kato T, Aoki Y, Higuchi T, Tsuchiya H. Cancer Med; 2015 Mar; 4(3):333-41. PubMed ID: 25533447 [Abstract] [Full Text] [Related]
5. Cancer and chemotherapy-induced nausea and vomiting: a focus on olanzapine. Bosnjak SM, Dimitrijevic J, Djordjevic F. Curr Opin Support Palliat Care; 2016 Jun; 10(2):180-8. PubMed ID: 27028050 [Abstract] [Full Text] [Related]
6. A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics. Hsu ES. Am J Ther; 2010 Jun; 17(5):476-86. PubMed ID: 20844345 [Abstract] [Full Text] [Related]
7. Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan. Tamura K, Aiba K, Saeki T, Nakanishi Y, Kamura T, Baba H, Yoshida K, Yamamoto N, Kitagawa Y, Maehara Y, Shimokawa M, Hirata K, Kitajima M, CINV Study Group of Japan. Int J Clin Oncol; 2015 Oct; 20(5):855-65. PubMed ID: 25681876 [Abstract] [Full Text] [Related]
9. State of the Art Antiemetic Therapy for Cancer Patients. Lau TK, Yip CH, Yeo W. Curr Oncol Rep; 2016 Jan; 18(1):2. PubMed ID: 26694923 [Abstract] [Full Text] [Related]
13. Aprepitant use in children, adolescents, and young adults for the control of chemotherapy-induced nausea and vomiting (CINV). Choi MR, Jiles C, Seibel NL. J Pediatr Hematol Oncol; 2010 Oct; 32(7):e268-71. PubMed ID: 20736848 [Abstract] [Full Text] [Related]
15. 2016 updated MASCC/ESMO consensus recommendations: Prevention of acute chemotherapy-induced nausea and vomiting in children. Dupuis LL, Sung L, Molassiotis A, Orsey AD, Tissing W, van de Wetering M. Support Care Cancer; 2017 Jan; 25(1):323-331. PubMed ID: 27565788 [Abstract] [Full Text] [Related]
16. Management of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients. Navari RM. Paediatr Drugs; 2017 Jun; 19(3):213-222. PubMed ID: 28447301 [Abstract] [Full Text] [Related]
20. Chemotherapy-induced Nausea and Vomiting in Patients with Hepatobiliary and Pancreatic Cancer Treated with Chemotherapy: A Prospective Observational Study by the CINV Study Group of Japan. Nitta H, Baba H, Sugimori K, Furuse J, Ohkawa S, Yamamoto K, Minami H, Shimokawa M, Wakabayashi GO, Aiba K, CINV Study Group of Japan. Anticancer Res; 2016 Apr; 36(4):1929-35. PubMed ID: 27069182 [Abstract] [Full Text] [Related] Page: [Next] [New Search]